Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: cause of disease or epiphenomenon?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Hematology
Link
https://link.springer.com/content/pdf/10.1007/s11239-021-02470-y.pdf
Reference91 articles.
1. Cui S, Chen S, Li X, Wang F (2020) Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 18(6):1421–1424
2. Klok FA, Kruip M, van der Meer NJM et al (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 191:145–147
3. Abou-Ismail MY, Diamon A, Kapoor S, Arafat Y, Nayak L (2020) The hypercoagulable state in COVID-19: incidence, pathophysiology, and management. Thromb Res 194:101–105
4. Marchandot B, Sattler L, Jesel L, Matsushita K, Schini-Kerth V, Grunebaum L, Morel O (2020) COVID-19 related coagulopathy: a distinct entity? J Clin Med 9(6):1651
5. Moschonas IC, Tselepis AD (2021) SARS-CoV-2 infection and thrombotic complications: a narrative review. J Thromb Thrombol 15:1–13
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Thromboembolic Disease and COVID-19: Experience of a University and Emergency Hospital During the Pandemic;Cureus;2024-09-06
2. Thrombosis and Hyperinflammation in COVID-19 Acute Phase Are Related to Anti-Phosphatidylserine and Anti-Phosphatidylinositol Antibody Positivity;Biomedicines;2023-08-18
3. Biological mechanisms underpinning the development of long COVID;iScience;2023-06
4. The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid‐19;The Clinical Respiratory Journal;2023-05-05
5. Factors Related to Severity, Hospitalization, and Mortality of COVID-19 Infection among Patients with Autoimmune Diseases;Tropical Medicine and Infectious Disease;2023-04-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3